Indivior Pharmaceuticals, Inc. Common Stock — Grafico, Quotazione e Notizie (NASDAQ:INDV)

Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche

Trimestrale Annuale

Market Capitalization 4.0577 B
Employee 838
Founded 2014
CEO Mark Crossley
Website www.indivior.com
Headquarter Delaware, United States
FIGI BBG01ZTXFLQ6
Industry Technology

Ricavi totali

Utile netto

Utile base per azione (EPS base)

Debito totale

Liquidità libera

Disponibilità liquide e mezzi equivalenti

4.06 B Capitalizzazione di mercato

Rapporto prezzo/utili

21.88

Rapporto prezzo/fatturato

3.71

Indivior Pharmaceuticals Inc

Indivior is an American pharmaceuticals company. Established as a division of Reckitt Benckiser in 1994 and demerged from that company in December 2014, it is focussed on substitution products for opioid addiction. It is listed on the London Stock Exchange and on the NASDAQ Global Select Market.

INDV

Financials

Indivior Pharmaceuticals Inc

Notizie

ALLO Rises on Strong MRD Clearance With Cema-Cel in ALPHA3 Study

Cipher Mining Stock, Five Below, Indivior Among 10 New Stocks On IBD Watchlists

SNY & REGN's Dupixent Gets EU Approval for Pediatric Use in Urticaria

ASML, An AI Megatrend Star, Leads 8 Newcomers To Best Stock Lists

IBRX Stock Rises 7% on Strong Q1 2026 Preliminary Results

KYMR Set to Earn Milestone Payment as GILD Secures License for KT-200

How Much Upside is Left in Indivior Pharmaceuticals Inc. (INDV)? Wall Street Analysts Think 45.99%

ACIU Stock Rallies 16.3% in a Week: Here's What You Need to Know

Soleno Therapeutics Stock Rallies 56.4% in a Week: Here's Why

Kodiak Q4 Loss Wider Than Expected, Pipeline Development in Focus

AGIO Rises on Mitapivat Progress Toward Accelerated Approval in SCD

Ultragenyx Pharmaceutical Announces FDA Acceptance of UX016 IND